https://www.selleckchem.com/pr....oducts/AR-42-HDAC-42
An amendment to this paper has been published and can be accessed via the original article. The synergistic effect of radiotherapy (RT) in combination with immunotherapy has been shown in several clinical trials and case reports. The overlapping pulmonary toxicity induced by thoracic RT and programmed death 1/programmed death ligand-1 (PD-1/PD-L1) blockades is an important issue of clinical investigation in combination treatment. Thus far, the underlying mechanism of this toxicity remains largely unknown. In this review, we discus
Like
Comment
Share
